FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Positive Results for Tecvayli/Darzalex Faspro Combo

[ Price : $8.95]

Johnson & Johnson says an independent data monitoring committee recommended unblinding the MajesTEC-3 study of Tecvayli and Darzal...

AI, RWE in FDA Decisions

[ Price : $8.95]

Hyman, Phelps & McNamara principal medical device regulation expert Adrienne Lenz says FDA is preparing for a future where artific...

FDA Urges High Court Rejection of Vanda Petition

[ Price : $8.95]

FDA urges the Supreme Court to reject Vanda Pharmaceuticals petition challenging the agencys decision to deny fast-track status fo...

3 Observations from Lupin Pithampur Inspection

[ Price : $8.95]

FDA releases the form FDA-483 with three observations from its inspection at the Lupin drug manufacturing facility in Pithampur, M...

Orphan Status for Minovia Myelodysplastic Drug

[ Price : $8.95]

Minovia Therapeutics wins an FDA orphan drug designation for its lead investigational therapy, MNV-201, for myelodysplastic syndro...

FDA Accepts Chiesis Triple Combination Asthma Inhaler

[ Price : $8.95]

FDA accepts for review a Chiesi NDA for a single-inhaler triple therapy designed for the maintenance treatment of asthma in adults...

Former Deputy Commissioner Bumpus Joins Charles River

[ Price : $8.95]

Charles River Laboratories names former FDA principal deputy commissioner Namandj N. Bumpus as chair a new global scientific advis...

FDA Warns on RF Microneedling Devices

[ Price : $8.95]

FDA warns of serious complications associated with certain uses of radiofrequency microneedling devices, commonly used in aestheti...

Trial Success for Lilly Oral GLP-1

[ Price : $8.95]

Lilly says its investigational oral GLP-1 drug demonstrated good glycemic control in two Phase 3 trials.

FDA Clears Roche Alzheimers Test

[ Price : $8.95]

FDA clears Roches Elecsys pTau 181 blood-based biomarker test for an initial Alzheimers disease assessment.